izpis_h1_title_alt

Stability of reduced and oxidized coenzyme Q10 in finished products
ID Temova Rakuša, Žane (Author), ID Kristl, Albin (Author), ID Roškar, Robert (Author)

.pdfPDF - Presentation file, Download (1,45 MB)
MD5: 79DB476869FB226BC0470D51868EF7BD
URLURL - Source URL, Visit https://www.mdpi.com/2076-3921/10/3/360 This link opens in a new window

Abstract
The efficiency of coenzyme Q10 (CoQ10) supplements is closely associated with its content and stability in finished products. This study aimed to provide evidence-based information on the quality and stability of CoQ10 in dietary supplements and medicines. Therefore, ubiquinol, ubiquinone, and total CoQ10 contents were determined by a validated HPLC-UV method in 11 commercial products with defined or undefined CoQ10 form. Both forms were detected in almost all tested products, resulting in a total of CoQ10 content between 82% and 166% of the declared. Ubiquinol, ubiquinone, and total CoQ10 stability in these products were evaluated within three months of accelerated stability testing. Ubiquinol, which is recognized as the less stable form, was properly stabilized. Contrarily, ubiquinone degradation and/or reduction were observed during storage in almost all tested products. These reactions were also detected at ambient temperature within the products shelf-lives and confirmed in ubiquinone standard solutions. Ubiquinol, generated by ubiquinone reduction with vitamin C during soft-shell capsules storage, may lead to higher bioavailability and health outcomes. However, such conversion and inappropriate content in products, which specify ubiquinone, are unacceptable in terms of regulation. Therefore, proper CoQ10 stabilization through final formulations regardless of the used CoQ10 form is needed.

Language:English
Keywords:assay, coenzyme Q10 content, commercial products, dietary supplements, HPLC-UV, medicines, reducing agent, stability, ubiquinol, ubiquinone
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2021
Number of pages:17 str.
Numbering:Vol. 10, iss. 3, art. 360
PID:20.500.12556/RUL-135060 This link opens in a new window
UDC:577.161.6:613.292
ISSN on article:2076-3921
DOI:10.3390/antiox10030360 This link opens in a new window
COBISS.SI-ID:53472259 This link opens in a new window
Publication date in RUL:18.02.2022
Views:1411
Downloads:146
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Antioxidants
Shortened title:Antioxidants
Publisher:MDPI
ISSN:2076-3921
COBISS.SI-ID:522976025 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:koencim 10, stabilnost učinkovin, ubikinon, prehranska dopolnila

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0189
Name:Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back